A comparison of three doses of lansoprazole (15, 30 and 60 mg) and placebo in the treatment of duodenal ulcer. The Lansoprazole Study Group

Lansoprazole is a new proton pump inhibitor for the treatment of peptic ulcer disease. A double-blind, multicentre study was undertaken in 296 patients with endoscopically proven duodenal ulcer to compare the efficacy and safety of lansoprazole 15, 30 or 60 mg with placebo. Ulcer healing was documen...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Alimentary pharmacology & therapeutics 1995-10, Vol.9 (5), p.521
Hauptverfasser:	Avner, D L, Dorsch, E R, Jennings, D E, Greski-Rose, P A
Format:	Artikel
Sprache:	eng
Schlagworte:	2-Pyridinylmethylsulfinylbenzimidazoles Abdominal Pain - drug therapy Adult Aged Anti-Ulcer Agents - administration & dosage Anti-Ulcer Agents - adverse effects Anti-Ulcer Agents - therapeutic use Double-Blind Method Duodenal Ulcer - blood Duodenal Ulcer - drug therapy Duodenoscopy Female Gastrins - blood Humans Lansoprazole Male Middle Aged Omeprazole - administration & dosage Omeprazole - adverse effects Omeprazole - analogs & derivatives Omeprazole - therapeutic use Treatment Outcome Wound Healing - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!